Telerehabilitation in COVID-19 Survivors

Bandırma Onyedi Eylül University36 enrolled

Overview

This study was carried out in the post-acute period of the telerehabilitation program in individuals with dyspnea who had COVID-19; It will be done to examine the effects on dyspnea, exercise capacity, respiratory functions, activities of daily living, muscle strength, muscle oxygenation, fatigue and quality of life parameters.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

DOUBLE

Enrollment

Conditions

COVID-19 Telerehabilitation

Interventions

telerehabilitationOTHER

While telerehabilitation sessions will be applied to the participants in the telerehabilitation group for 6 weeks, home exercise program will be given to the home exercise program group and will be applied for 6 weeks.

home exercise programOTHER

informed programOTHER

will informed after COVID 19

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with COVID-19 by Computed Tomography (CT) or PCR test between the ages of 18-75, * Do not have any orthopedic or neurological disease that will affect exercise capacity, * Individuals who can take and execute verbal orders, * Have had COVID-19 and at least 2 weeks have passed since the completion of the treatment, * Individuals who have a computer or smart phone with a camera and internet connection and have the ability to use it (the participant himself or one of his family members living in the same house), * Individuals who are sedentary (those whose physical activity level is inactive according to the Turkish version of the International Physical Activity Questionnaire (UFAA)), * Having dyspnea at level 2 or 3 on the Medical Research Council Dyspnea Scale. Exclusion Criteria: * Those who have not had COVID-19 or acute period patients who are experiencing COVID-19, * Individuals who cannot be contacted, * Individuals with chronic heart disease, * Those with concomitant uncontrolled disease; uncontrolled hypertension (resting blood pressure ≥160 /100mmHg), uncontrolled diabetes (random instantaneous blood glucose\>16.7 mmol/l, HbA1C\>7.0%), * Those with concomitant severe organic disease (unstable hemodynamic heart disease, heart failure causing movement limitation, unstable angina, MI or other cardiac disease in the last 12 years), * Individuals with cerebrovascular disease in the last 6 months, * Those with digestive system ulcer, thyroid dysfunction or active stage of tuberculosis, * Patients with Chronic Kidney Failure stage 3 and above according to Glomerular Filtration Rate (GFR), * Individuals who have undergone intraraticular medication or surgery from their lower extremities in the last 6 months, * Individuals who cannot walk independently, * Individuals with any mental illness that may prevent them from living independently or receiving treatment, * Uncooperative individuals for assessment and rehabilitation programs, * Those with alcohol or substance addiction, * Those who are pregnant, suspected of pregnancy or considering becoming pregnant, * Participants in another study within the last 3 months or currently.

Locations (1)

Bandırma Onyedi Eylül University, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department

Balıkesir, Bandırma, Turkey (Türkiye)

Outcomes

Primary Outcomes

Severity of dyspnea assessment

Medical Research Council (MRC) Dyspnea Scale will be used to assess the severity of dyspnea. The severity of dyspnea during activities of daily living is graded from 0 to 4 on the Medical Research Council (MRC) Dyspnea Scale.

Time frame: 6 weeks

Physical activity level assessment

The physical activity level of the participants will be evaluated with the Turkish version of the "International Physical Activity Questionnaire" (UFAA).In the last 7 days with the survey; Vigorous physical activity (football, basketball, aerobics, cycling fast, lifting weights, carrying loads, etc.) time (min), Intermediate physical activity (light weight carrying, cycling at normal speed, folk dances, dancing, bowling, table tennis etc.) duration (min), walking and sitting times for one day (min) are questioned. All participants were given pre-study to assess the condition of being sedentary and those with inactive physical activity levels will be included in the study.

Time frame: 6 weeks

Cardiopulmonary endurance assessment

In order to evaluate cardiopulmonary endurance; A six-minute walking test will be applied. The test is 30 meters long, every 3 meters marked, the start and finish line are marked by a visible line, a smooth and straight done on the track. The distance the person walks for 6 minutes is recorded in meters.

Time frame: 6 weeks

Evaluation of peripheral muscle oxygenation

"Moxy muscle oxygen monitor" will be used to measure regional oxygen saturation (SmO2) and total hemoglobin (Thb) amount in capillaries under the muscle. Moxy muscle oxygen monitor (Fortiori Design LLC, USA) near infrared It is placed on the skin in a non-invasive way with spectroscopy (NIRS), It is a device that regional blood flow and measures oxygenation. A moxy muscle oxygen monitor will be attached to the quadriceps femoris muscle of the participants with a velcro and oxygenation measurements will be taken during both the dinelnim and 6-minute walking test.

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.